The historic rise of Viagra has firmly established as a symbol of pharmaceutical success, however its legacy within the broader market now presents questions about potential yields . Copycat versions are eroding exclusivity , prompting worries that investing in companies significantly dependent to Viagra's former position could be a problematic mov